Kiniksa Pharmaceuticals

Kiniksa is a global biopharmaceutical company that discovers, acquires, develops, and commercializes therapeutic medicines for patients with debilitating diseases and significant unmet medical needs. Its immune-modulating portfolio and pipeline target underserved conditions, with a focus on cardiovascular diseases and programs addressing autoimmune conditions. The company advances novel therapies based on strong biological rationale or validated mechanisms, with an FDA-approved therapy and additional clinical-stage assets.